Advertisement

Sports Fan Unicorn

Campaign
Agency Network: 
Published/Aired: 
November 2017

Description

For the past 30 years, a diagnosis of acute myeloid leukemia (AML) has been a death sentence for many patients. Unlike most other forms of cancer, treatment advances have been few and far between, and an archaic chemo cocktail remains the decades-long standard of care. This has lead to the worst 5-year survival rate of any form of adult leukemia, and the hope for long-term survival little more than wishful thinking.

Now with Rydapt, the future has become brighter. As the first targeted agent approved in decades, patients will finally experience the benefit of sustained survival benefits. The Unicorn, embedded in everyday scenarios like the subway, represents how the myth of extended survival is finally a reality in AML.

Print advertisement created by Harrison and Star, United States for Novartis, within the category: Pharmaceutical.

Caption

Make the Myth of Extended Survival a Reality
Introducing RYDAPT, a treatment for adults with newly diagnosed FLT3+ AML eligible for intensive chemotherapy

Log in or register to post comments

Highest Rated

kleenex's picture

I pass.

kleenex
Activity Score 55199
Web Designer/Developer
kleenex's picture

I pass.

kleenex
Activity Score 55199
Web Designer/Developer
KimSoto's picture

Ugh... horrible campaign. And even worse reading the description of it! I’m a patient with AML. This ad makes me feel like I’m going to DIE. And actually Rydapt is targeted at a specific mutation that is a hard to treat type of AML. It is a medical breakthrough. Not a myth. Shame on Novartis for spending money on this crap. My doctor would never select a unicorn for my treatment either!

KimSoto
Activity Score 2
Advertisement
Featured Content

Latest Collections

Advertisement
Advertisement